Caricamento...
Pharmacokinetics of Belimumab in Children With Systemic Lupus Erythematosus
The phase 2 placebo‐controlled, double‐blind PLUTO trial characterized the pharmacokinetics of belimumab plus standard systemic lupus erythematosus (SLE) therapy in patients with childhood‐onset SLE (cSLE) and demonstrated similar efficacy and safety to that in adult SLE. Patients with active cSLE a...
Salvato in:
| Pubblicato in: | Clin Pharmacol Drug Dev |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8246766/ https://ncbi.nlm.nih.gov/pubmed/33245847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.889 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|